| 臺大學術典藏 |
2020-03-06T08:25:38Z |
Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer
|
Liang J.-T.; Huang K.-C.; YUNG-MING JENG; Lee P.-H.; Lai H.-S.; Hsu H.-C.; Liang J.-T.;Huang K.-C.;Yung-Ming Jeng;Lee P.-H.;Lai H.-S.;Hsu H.-C. |
| 臺大學術典藏 |
2020-03-06T08:25:37Z |
High α-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and β-catenin mutations
|
Hsu H.-C.; Lai P.-L.; YUNG-MING JENG; Sheu J.-C.; Chen W.J.; Peng S.-Y.; Peng S.-Y.;Chen W.J.;Lai P.-L.;Yung-Ming Jeng;Sheu J.-C.;Hsu H.-C. |
| 臺大學術典藏 |
2020-03-06T08:25:37Z |
RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts
|
Tsuei D.-J.;Hsu H.-C.;Lee P.-H.;Yung-Ming Jeng;Pu Y.-S.;Chen C.-N.;Lee Y.-C.;Chou W.-C.;Chang C.-J.;Ni Y.-H.;Chang M.-H.; Tsuei D.-J.; Hsu H.-C.; Lee P.-H.; YUNG-MING JENG; Pu Y.-S.; Chen C.-N.; Lee Y.-C.; Chou W.-C.; Chang C.-J.; Ni Y.-H.; Chang M.-H. |
| 臺大學術典藏 |
2020-03-06T08:25:36Z |
Aberrant expressions of annexin A10 short isoform, osteopontin and alpha-fetoprotein at chromosome 4q cooperatively contribute to progression and poor prognosis of hepatocellular carcinoma.
|
Peng S.Y.;Ou Y.H.;Chen W.J.;Li H.Y.;Liu S.H.;Pan H.W.;Lai P.L.;Yung-Ming Jeng;Chen D.C.;Hsu H.C.; Peng S.Y.; Ou Y.H.; Chen W.J.; Li H.Y.; Liu S.H.; Pan H.W.; Lai P.L.; YUNG-MING JENG; Chen D.C.; Hsu H.C. |
| 臺大學術典藏 |
2020-03-06T08:25:34Z |
Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: Association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, β-catenin mutation, and favorable prognosis
|
Yuan R.-H.;Yung-Ming Jeng;Chen H.-L.;Hsieh F.-J.;Yang C.-Y.;Lee P.-H.;Hsu H.-C.; Yuan R.-H.; YUNG-MING JENG; Chen H.-L.; Hsieh F.-J.; Yang C.-Y.; Lee P.-H.; Hsu H.-C. |
| 臺大學術典藏 |
2020-03-06T08:25:32Z |
Overexpression of pituitary tumor-transforming gene-1 in hepatocellular carcinoma
|
Su M.-C.;Hsu H.-C.;Liu Y.-J.;Yung-Ming Jeng; Su M.-C.; Hsu H.-C.; Liu Y.-J.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T08:25:31Z |
Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma
|
Yuan R.-H.;Yung-Ming Jeng;Chen H.-L.;Lai P.-L.;Pan H.-W.;Hsieh F.-J.;Lin C.-Y.;Lee P.H.;Hsu H.-C.; Yuan R.-H.; YUNG-MING JENG; Chen H.-L.; Lai P.-L.; Pan H.-W.; Hsieh F.-J.; Lin C.-Y.; Lee P.H.; Hsu H.-C. |
| 臺大學術典藏 |
2020-03-06T08:25:28Z |
Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma
|
Yuan R.-H.;Yung-Ming Jeng;Pan H.-W.;Hu F.-C.;Lai P.-L.;Lee P.-H.;Hsu H.-C.; Yuan R.-H.; YUNG-MING JENG; Pan H.-W.; Hu F.-C.; Lai P.-L.; Lee P.-H.; Hsu H.-C. |
| 臺大學術典藏 |
2020-03-06T08:25:27Z |
Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma
|
Lin C.-Y.; YUNG-MING JENG; Chou H.-Y.; Hsu H.-C.; Yuan R.-H.; Chiang C.-P.; Kuo M.Y.-P. |
| 臺大學術典藏 |
2020-03-06T08:25:27Z |
Frequent nuclear expression of β-catenin protein but rare β-catenin mutation in pulmonary sclerosing haemangioma
|
Chiang P.-M.; Yuan R.-H.; Hsu H.-C.; Mao T.-L.; Hu R.-H.; Lai P.-L.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T08:25:26Z |
RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma
|
YUNG-MING JENG; Chang C.-C.; Hu F.-C.; Chou H.-Y.E.; Kao H.-L.; Wang T.-H.; Hsu H.-C. |
| 臺大學術典藏 |
2020-03-06T08:25:26Z |
ASPM\s a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma
|
Lin S.-Y.; Pan H.-W.; Liu S.-H.; YUNG-MING JENG; Hu F.-C.; Peng S.-Y.; Lai P.-L.; Hsu H.-C. |
| 臺大學術典藏 |
2020-03-06T08:25:25Z |
Prognostic significance of insulin-like growth factor II mRNA-binding protein 3 expression in gastric adenocarcinoma
|
YUNG-MING JENG; Wang T.-H.; Lu S.-H.; Yuan R.-H.; Hsu H.-C. |
| 臺大學術典藏 |
2020-03-06T08:25:24Z |
The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma
|
Cheng A.-L.; Chung Y.; YUNG-MING JENG; Hu F.-C.; Hsu C.; Kuo S.-H.; Chen T.-J.; Huang Y.-F.; Huang C.-Y.F.; Yeh P.-Y.; Hsu C.-H.; Hsu H.-C.; Lin Z.-Z. |
| 臺大學術典藏 |
2020-03-06T08:25:20Z |
Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma
|
Wang Y.-C.;Chen Y.-L.;Yuan R.-H.;Pan H.-W.;Yang W.-C.;Hsu H.-C.;Yung-Ming Jeng; Wang Y.-C.; Chen Y.-L.; Yuan R.-H.; Pan H.-W.; Yang W.-C.; Hsu H.-C.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T08:25:18Z |
Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression
|
Yu T.-H. ;Yuan R.-H. ;Chen Y.-L. ;Yang W.-C. ;Hsu H.-C. ;Yung-Ming Jeng; Yu T.-H.; Yuan R.-H.; Chen Y.-L.; Yang W.-C.; Hsu H.-C.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T08:25:18Z |
Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma
|
Yuan R.-H. ;Yung-Ming Jeng ;Hu R.-H. ;Lai P.-L. ;Lee P.-H. ;Cheng C.-C. ;Hsu H.-C.; Yuan R.-H.; YUNG-MING JENG; Hu R.-H.; Lai P.-L.; Lee P.-H.; Cheng C.-C.; Hsu H.-C. |
| 臺大學術典藏 |
2020-03-06T08:25:16Z |
Male germ cell-specific RNA binding protein RBMY: A new oncogene explaining male predominance in liver cancer
|
Tsuei D.-J. ;Lee P.-H. ;Peng H.-Y. ;Lu S.-L. ;Su D.-S. ;Yung-Ming Jeng ;Hsu H.-C. ;Hsu S.-H. ;Wu J.-F. ;Ni Y.-H. ;Chang M.-H.; Tsuei D.-J.; Lee P.-H.; Peng H.-Y.; Lu S.-L.; Su D.-S.; YUNG-MING JENG; Hsu H.-C.; Hsu S.-H.; Wu J.-F.; Ni Y.-H.; Chang M.-H. |
| 臺大學術典藏 |
2020-03-06T08:25:15Z |
SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis
|
Chen H.-C.; YUNG-MING JENG; Yuan R.-H.; Hsu H.-C.; Chen Y.-L. |
| 臺大學術典藏 |
2020-03-06T08:25:12Z |
Expression of insulin-like growth factor II mRNA-binding protein 3 predicts early recurrence and poor prognosis in intrahepatic cholangiocarcinoma
|
Chen Y.-L.; YUNG-MING JENG; Hsu H.-C.; Lai H.-S.; Lee P.-H.; Lai P.-L.; Yuan R.-H. |
| 臺大學術典藏 |
2020-03-06T08:25:11Z |
The stem cell E3-ligase Lin-41 promotes liver cancer progression through inhibition of microRNA-mediated gene silencing
|
Chen Y.-L.; Yuan R.-H.; YUNG-MING JENG; Hsu H.-C.; Yang W.-C. |
| 臺大學術典藏 |
2020-03-06T08:25:09Z |
S100P Expression Is a Novel Prognostic Factor in Hepatocellular Carcinoma and Predicts Survival in Patients with High Tumor Stage or Early Recurrent Tumors
|
Yuan R.-H.; Chang K.-T.; Chen Y.-L.; Hsu H.-C.; Lee P.-H.; Lai P.-L.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T08:25:08Z |
Overexpression of CTHRC1 in Hepatocellular Carcinoma Promotes Tumor Invasion and Predicts Poor Prognosis
|
Chen Y.-L.; Wang T.-H.; Hsu H.-C.; Yuan R.-H.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T08:25:08Z |
Annexin A10 is an immunohistochemical marker for adenocarcinoma of the upper gastrointestinal tract and pancreatobiliary system
|
Lu S.-H.; Yuan R.-H.; Chen Y.-L.; Hsu H.-C.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T08:25:07Z |
Upregulation of endocan by epstein-barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal Carcinoma
|
Yu P.-H.; Chou S.-F.; Chen C.-L.; Hung H.; Lai C.-Y.; Yang P.-M.; YUNG-MING JENG; Liaw S.-F.; Kuo H.-H.; Hsu H.-C.; Chen J.-Y.; Wang W.-B. |
